631 ASSESSMENT OF SERUM HCV-RNA AT WEEK 12 POST-TREATMENT IS AS RELEVANT AS WEEK 24 TO PREDICT SVR IN HCV PATIENTS RECEIVING PEGINTERFERON PLUS RIBAVIRINM. Martinot-Peignoux,C. Stern,M.P. Ripault,L. Leclere,N. Boyer,P. MarcellinJournal of Hepatology（2009）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
